109 related articles for article (PubMed ID: 26726791)
1. Legal Highs, Lethal Lows.
Shah B; Heaps T
Acute Med; 2015; 14(4):188-92. PubMed ID: 26726791
[TBL] [Abstract][Full Text] [Related]
2. "Legal Highs"--An Emerging Epidemic of Novel Psychoactive Substances.
Zawilska JB
Int Rev Neurobiol; 2015; 120():273-300. PubMed ID: 26070762
[TBL] [Abstract][Full Text] [Related]
3. 'Ivory wave' toxicity in recreational drug users; integration of clinical and poisons information services to manage legal high poisoning.
Murray DB; Potts S; Haxton C; Jackson G; Sandilands EA; Ramsey J; Puchnarewicz M; Holt DW; Johnston A; Nicholas Bateman D; Dear JW
Clin Toxicol (Phila); 2012 Feb; 50(2):108-13. PubMed ID: 22224933
[TBL] [Abstract][Full Text] [Related]
4. A chemical analysis examining the pharmacology of novel psychoactive substances freely available over the internet and their impact on public (ill)health. Legal highs or illegal highs?
Ayres TC; Bond JW
BMJ Open; 2012; 2(4):. PubMed ID: 22855623
[TBL] [Abstract][Full Text] [Related]
5. Buying 'legal' recreational drugs does not mean that you are not breaking the law.
Ramsey J; Dargan PI; Smyllie M; Davies S; Button J; Holt DW; Wood DM
QJM; 2010 Oct; 103(10):777-83. PubMed ID: 20675395
[TBL] [Abstract][Full Text] [Related]
6. When good times go bad: managing 'legal high' complications in the emergency department.
Caffrey CR; Lank PM
Open Access Emerg Med; 2018; 10():9-23. PubMed ID: 29302196
[TBL] [Abstract][Full Text] [Related]
7. Issues with monitoring the safety of psychoactive products under a legal regulated market for new psychoactive substances ('legal highs') in New Zealand.
Rychert M; Wilkins C; Witten K
Drug Alcohol Rev; 2017 Sep; 36(5):589-596. PubMed ID: 28229493
[TBL] [Abstract][Full Text] [Related]
8. A critical analysis of national policy relating to legal highs.
Sarpong I; Jones F
Nurs Stand; 2014 Sep; 28(52):35-41. PubMed ID: 25159975
[TBL] [Abstract][Full Text] [Related]
9. Raising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of 'legal high' packages containing synthetic cathinones.
Araújo AM; Valente MJ; Carvalho M; Dias da Silva D; Gaspar H; Carvalho F; de Lourdes Bastos M; Guedes de Pinho P
Arch Toxicol; 2015 May; 89(5):757-71. PubMed ID: 24903018
[TBL] [Abstract][Full Text] [Related]
10. The challenge of a ban on animal testing for the development of a regulated legal market for new psychoactive substances (NPS) ('legal highs') in New Zealand: Issues and options for resolution.
Rychert M; Wilkins C
Int J Drug Policy; 2015 Dec; 26(12):1273-8. PubMed ID: 26364077
[TBL] [Abstract][Full Text] [Related]
11. What products are considered psychoactive under New Zealand's legal market for new psychoactive substances (NPS, 'legal highs')? Implications for law enforcement and penalties.
Rychert M; Wilkins C
Drug Test Anal; 2016 Aug; 8(8):768-78. PubMed ID: 26857892
[TBL] [Abstract][Full Text] [Related]
12. Analysis of psychoactive and intoxicating substances in legal highs.
Żukiewicz-Sobczak W; Zwoliński J; Chmielewska-Badora J; Krasowska E; Piątek J; Sobczak P; Wojtyła A; Fornal E; Kuczumow A; Biliński P
Ann Agric Environ Med; 2012; 19(2):309-14. PubMed ID: 22742807
[TBL] [Abstract][Full Text] [Related]
13. Use and acute toxicity associated with the novel psychoactive substances diphenylprolinol (D2PM) and desoxypipradrol (2-DPMP).
Wood DM; Dargan PI
Clin Toxicol (Phila); 2012 Sep; 50(8):727-32. PubMed ID: 22882169
[TBL] [Abstract][Full Text] [Related]
14. The potential utility of some legal highs in CNS disorders.
Davidson C; Schifano F
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():267-74. PubMed ID: 26232510
[TBL] [Abstract][Full Text] [Related]
15. Can new psychoactive substances be regulated effectively? An assessment of the British Psychoactive Substances Bill.
Reuter P; Pardo B
Addiction; 2017 Jan; 112(1):25-31. PubMed ID: 27220685
[TBL] [Abstract][Full Text] [Related]
16. 'Legal highs'--novel and emerging psychoactive drugs: a chemical overview for the toxicologist.
Gibbons S
Clin Toxicol (Phila); 2012 Jan; 50(1):15-24. PubMed ID: 22248120
[TBL] [Abstract][Full Text] [Related]
17. Legal highs toxicity--symptomatology and clinical diagnosis in case series.
Łukasik-Głebock M; Sommerfeld K; Nawrocka K
Przegl Lek; 2010; 67(8):613-6. PubMed ID: 21384787
[TBL] [Abstract][Full Text] [Related]
18. Managing misuse of novel psychoactive substances.
Solomon D; Grewal P; Taylor C; Solomon B
Nurs Times; 2014 May 28-Jun 3; 110(22):12-5. PubMed ID: 24984370
[TBL] [Abstract][Full Text] [Related]
19. The impact of the prohibition of benzylpiperazine (BZP) 'legal highs' on the prevalence of BZP, new legal highs and other drug use in New Zealand.
Wilkins C; Sweetsur P
Drug Alcohol Depend; 2013 Jan; 127(1-3):72-80. PubMed ID: 22819869
[TBL] [Abstract][Full Text] [Related]
20. Wide-range screening of psychoactive substances by FIA-HRMS: identification strategies.
Alechaga É; Moyano E; Galceran MT
Anal Bioanal Chem; 2015 Jun; 407(16):4567-80. PubMed ID: 25862473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
